'Sifting the significance from the data' - The impact of high-throughput genomic technologies on human genetics and health care

Human Genomics

Volumn 6, Issue 1, 2012, Pages

  Clarke, Angus J ^a   Cooper, David N ^a   Krawczak, Michael ^b   Tyler Smith, Chris ^c   Wallace, Helen M ^d   Wilkie, Andrew O M ^e   Raymond, Frances Lucy ^f   Chadwick, Ruth ^a   Craddock, Nick ^g   John, Ros ^h   Gallacher, John ^a   Chiano, Mathias ⁱ  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d GeneWatch UK ^*  (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^h CARDIFF UNIVERSITY   (United Kingdom)

ⁱ GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN GENETICS; HUMAN GENOME PROJECT; MOSAICISM; PHARMACOGENETICS; TECHNOLOGY; CHROMOSOME MAP; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETIC SELECTION; HIGH THROUGHPUT SCREENING; HUMAN GENOME; MEDICAL GENETICS; METHODOLOGY; PHENOTYPE;

CHROMOSOME MAPPING; EPIGENOMICS; GENE-ENVIRONMENT INTERACTION; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENETICS, MEDICAL; GENOME, HUMAN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PHARMACOGENETICS; PHENOTYPE; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84876579077     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-6-11     Document Type: Article

References (68)

1. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N: Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49.
2. Tarpey PS, Smith R, Pleasance E, Whibley A, Edkins S, Hardy C, O'Meara S, Latimer C, Dicks E, Menzies A, Stephens P, Blow M, Greenman C, Xue Y, Tyler-Smith C, Thompson D, Gray K, Andrews J, Barthorpe S, Buck G, Cole J, Dunmore R, Jones D, Maddison M, Mironenko T, Turner R, Turrell K, Varian J, West S, Widaa S, et al: A systematic large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet 2009, 41:535-543.
3. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, Bamshad M, Nickerson DA, Shendure J: Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461:272-276.
4. Cooper DN, Chen JM, Ball EV, Howells K, Mort M, Phillips AD, Chuzhanova N, Krawczak M, Kehrer-Sawatzki H, Stenson PD: Genes mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 2010, 31:631-655.
5. MacArthur DG, Tyler-Smith C: Loss-of-function variants in the genomes of healthy humans. Hum Mol Genet 2010, 19:R125-R130.
6. Raymond FL, Whibley A, Stratton MR, Gecz J: Lessons learnt from largescale exon re-sequencing of the X chromosome. Hum Mol Genet 2009, 18: R60-R64.
7. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, Mills IG: Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 2011, 43:513-518.
8. Schulz LC: The Dutch Hunger Winter and the developmental origins of health and disease. Proc Natl Acad of Sci USA 2010, 107:16757-16758.
9. Morgan HD, Sutherland HG, Martin DI, Whitelaw E: Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 1999, 23:314-318.
10. Gluckman P, Hanson M: The Fetal Matrix. Evolution, Development and Disease. Cambridge: Cambridge University Press; 2005.
11. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Gräf S, Johnson N, Herrero J, Tomazou EM, Thorne NP, Bäckdahl L, Herberth M, Howe KL, Jackson DK, Miretti MM, Marioni JC, Birney E, Hubbard TJ, Durbin R, Tavaré S, Beck S: A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 2008, 26:779-785.
12. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O'Geen H, Lister R, Pelizzola M, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, et al: Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 2010, 28:1097-1105.
13. Bock C, Tomazou EM, Brinkman AB, Müller F, Simmer F, Gu H, Jäger N, Gnirke A, Stunnenberg HG, Meissner A: Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 2010, 28:1106-1114.
14. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
15. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K: High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
16. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
17. Charlesworth B: Effective population size and patterns of molecular evolution and variation. Nat Rev Genet 2009, 10:195-205.
18. Flint J, Mott R: Applying mouse complex-trait resources to behavioural genetics. Nature 2008, 456:724-727.
19. Emily M, Mailund T, Hein J, Schauser L, Schierup MH: Using biological networks to search for interacting loci in genome-wide association studies. Eur J Hum Genet 2009, 17:1231-1234.
20. Bradford-Hill A: The environment and disease: association or causation? Proc R Soc Med 1965, 58:295-300.
21. Reich DE, Lander ES: On the allelic spectrum of human disease. Trends in Genetics 2001, 17:502-510.
22. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.
23. Clerget-Darpoux F, Elston RC: Are linkage analysis and the collection of family data dead? Prospects for family studies in the age of genomewide association. Hum Hered 2007, 64:91-96.
24. Hernandez RD, Kelley JL, Elyashiv E, Melton SC, Auton A, McVean G, 1000 Genomes Project, Sella G, Przeworski M: Classic selective sweeps were rare in recent human evolution. Science 2011, 331:920-924.
25. Xue Y, Zhang X, Huang N, Daly A, Gillson CJ, Macarthur DG, Yngvadottir B, Nica AC, Woodwark C, Chen Y, Conrad DF, Ayub Q, Mehdi SQ, Li P, Tyler-Smith C: Population differentiation as an indicator of recent positive selection in humans: an empirical evaluation. Genetics 2009, 183:1065-1077.
26. Laland KN, Odling-Smee J, Myles S: How culture shaped the human genome: bringing genetics and the human sciences together. Nat Rev Genet 2010, 11:137-148.
27. The 1000 Genomes Consortium: A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
28. De S: Somatic mosaicism in healthy human tissues. Trends in Genetics 2011, 27:217-223.
29. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, Steidl C, Holt RA, Jones S, Sun M, Leung G, Moore R, Severson T, Taylor GA, Teschendorff AE, Tse K, Turashvili G, Varhol R, Warren RL, Watson P, Zhao Y, Caldas C, Huntsman D, Hirst M, Marra MA, Aparicio S: Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813.
30. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP: Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011, 57:1042-1049.
31. Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B: Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci USA 2011, 108:9530-9535.
32. Chiu RWK, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM: Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. British Medical Journal 2011, 342. doi:10.1136/bmj.c7401.
33. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR, Chiu RW: Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine 2010, 2:61-91.
34. Williams HJ, Craddock N, Russo G, Hamshere ML, Moskvina V, Dwyer S, Smith RL, Green E, Grozeva D, Holmans P, Owen MJ, O'Donovan MC: Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet 2011, 20:387-391.
35. Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, Gordon-Smith K, Fraser C, Forty L, Russell E, Hamshere ML, Moskvina V, Nikolov I, Farmer A, McGuffin P, Wellcome Trust Case Control Consortium, Holmans PA, Owen MJ, O'Donovan MC, Craddock N: The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry 2010, 15:1016-1022.
36. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L, Dionne-Laporte A, Spiegelman D, Henrion E, Diallo O, Thibodeau P, Bachand I, Bao JY, Tong AH, Lin CH, Millet B, Jaafari N, Joober R, Dion PA, Lok S, Krebs MO, Rouleau GA: Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011, 43:860-863.
37. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M: Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011, 43:864-868.
38. Nachman MW, Crowell SL: Estimate of the mutation rate per nucleotide in humans. Genetics 2000, 156:297-304.
39. Kondrashov AS: Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases. Hum Mutat 2003, 21:12-27.
40. Ponting CP, Lunter G: Signatures of adaptive evolution within human non-coding sequence. Hum Mol Genet 2006, 15:R170-175.
41. Eyre-Walker A, Keightley PD: The distribution of fitness effects of new mutations. Nat Rev Genet 2007, 8:610-618.
42. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, Shannon PT, Rowen L, Pant KP, Goodman N, Bamshad M, Shendure J, Drmanac R, Jorde LB, Hood L, Galas DJ: Analysis of genetic inheritance in a family quartet by wholegenome sequencing. Science 2010, 328:636-639.
43. Goriely A, McVean GA, Röjmyr M, Ingemarsson B, Wilkie AO: Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 2003, 301:643-646.
44. Goriely A, McVean GA, van Pelt AM, O'Rourke AW, Wall SA, de Rooij DG, Wilkie AO: Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci USA 2005, 102:6051-6056.
45. Qin J, Calabrese P, Tiemann-Boege I, Shinde DN, Yoon SR, Gelfand D, Bauer K, Arnheim N: The molecular anatomy of spontaneous germline mutations in human testes. Public Library of Science Biology 2007, 5:e224.
46. Goriely A, Hansen RM, Taylor IB, Olesen IA, Jacobsen GK, McGowan SJ, Pfeifer SP, McVean GA, Rajpert-De Meyts E, Wilkie AO: Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 2009, 41:1247-1252.
47. Goriely A, Wilkie AOM: Missing heritability: paternal age effect mutations and selfish spermatogonia. Nat Rev Genet 2010, 11:589.
48. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Möller HJ, Hartmann A, et al: Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
49. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
50. Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, Stefansson H, Stefansson K, Magnusson P, Gudmundsson OO, Gustafsson O, Holmans P, Owen MJ, O'Donovan M, Thapar A: Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376:1401-1408.
51. Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT: Association between presence of HLA-B*5701 HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002, 359:727-732.
52. Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A, PREDICT-1 Study Team: HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008, 358:568-578.
53. Furness P, Zimmern R, Wright C, Adams M: The Evaluation of Diagnostic Laboratory Tests and Complex Biomarkers. Cambridge and The Royal College of Pathologists, London: Public Health Genetics Foundation; 2008.
54. Manson N, O'Neill O: Rethinking Informed Consent in Bioethics. Cambridge, England: Cambridge University Press; 2007.
55. Lobb EA, Barlow-Stewart K, Suthers G, Hallowell N: Treatment-focused DNA testing for newly diagnosed breast cancer patients: some implications for clinical practice. Clin Genet 2010, 77:350-354.
56. Wood F, Kowalczuk J, Elwyn G, Mitchell C, Gallacher J: Achieving online consent to participation in large-scale gene-environment studies: a tangible destination. Journal of Medical Ethics 2011, 37:487-492.
57. Lunshof J, Chadwick R, Vorhaus D, Church G: From genetic privacy to open consent. Nat Rev Genet 2008, 9:406-411.
58. Knoppers BM: Consent to 'personal' genomics and privacy. European Molecular Biology Reports 2010, 11:416-419.
59. Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, Pushkarev D, Neff NF, Hudgins L, Gong L, Hodges LM, Berlin DS, Thorn CF, Sangkuhl K, Hebert JM, Woon M, Sagreiya H, Whaley R, Knowles JW, Chou MF, Thakuria JV, Rosenbaum AM, Zaranek AW, Church GM, Greely HT, Quake SR, et al: Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.
60. Khoury MJ, Wagener DK: Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet 1995, 56:835-844.
61. Wallace HM: Model of gene-gene and gene-environment interactions and its implications for targeting environmental interventions by genotype. Theoretical Biology and Medical Modelling 2006, 3:35.
62. Terwilliger JD, Weiss KM: Confounding ascertainment bias, and the blind quest for a genetic 'fountain of youth'. Annals of Medicine 2003, 35:532-544.
63. Guo S: The behaviors of some heritability estimators in the complete absence of genetic factors. Hum Hered 1999, 49:215-228.
64. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, Madden PA, Heath AC, Martin NG, Montgomery GW, Goddard ME, Visscher PM: Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010, 42:565-569.
65. Visscher PM, Yang J, Goddard ME: A commentary on 'common SNPs explain a large proportion of the heritability for human height' by Yang et al (2010). Twin Research and Human Genetics 2010, 13:517-24.
66. Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, Onland-Moret NC, Lettre G, Ongen H, Rajagopalan R, Johnson T, Shen H, Nelson CP, Klopp N, Baumert J, Padmanabhan S, Pankratz N, Pankow JS, Shah S, Taylor K, Barnard J, Peters BJ, Maloney CM, Lobmeyer MT, Stanton A, Zafarmand MH, Romaine SP, Mehta A, van Iperen EP, Gong Y, Price TS, et al: Meta-analysis of Dense Genecentric Association Studies reveals common and uncommon variants associated with height. Am J Hum Genet 2011, 88:6-18.
67. So HC, Li M, Sham PC: Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genetic Epidemiology 2011, 35:447-456.
68. Kahn SD: On the future of genomic data. Science 2011, 331:728-729.